» Articles » PMID: 19208356

Notch Signaling As Gatekeeper of Rat Acinar-to-beta-cell Conversion in Vitro

Overview
Specialty Gastroenterology
Date 2009 Feb 12
PMID 19208356
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Exocrine acinar cells in the pancreas are highly differentiated cells that retain a remarkable degree of plasticity. After isolation and an initial phase of dedifferentiation in vitro, rodent acinar cells can convert to endocrine beta-cells when cultured in the presence of appropriate factors. The mechanisms regulating this phenotypic conversion are largely unknown.

Methods: Using rat acinar cell cultures, we studied the role of Notch signaling in a model of acinar-to-beta-cell conversion.

Results: We report a novel lectin-based cell labeling method to demonstrate the acinar origin of newly formed insulin-expressing beta-cells. This method allows for specific tracing of the acinar cells. We demonstrate that growth factor-induced conversion of adult acinar cells to beta-cells is negatively regulated by Notch1 signaling. Activated Notch1 signaling prevents the reexpression of the proendocrine transcription factor Neurogenin-3, the key regulator of endocrine development in the embryonic pancreas. Interfering with Notch1 signaling allows modulating the acinar cell susceptibility to the differentiation-inducing factors. Its inhibition significantly improves beta-cell neoformation with approximately 30% of acinar cells that convert to beta-cells. The newly formed beta-cells mature when transplanted ectopically and are capable of restoring normal blood glycemia in diabetic recipients.

Conclusions: We report for the first time an efficient way to reprogram one third of the acinar cells to beta-cells by adult cell type conversion. This could find application in cell replacement therapy of type 1 diabetes, provided that it can be translated from rodent to human models.

Citing Articles

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status.

Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C Signal Transduct Target Ther. 2025; 10(1):39.

PMID: 39948335 PMC: 11825823. DOI: 10.1038/s41392-024-02098-3.


Low expression of CCKBR in the acinar cells is associated with insufficient starch hydrolysis in ruminants.

Cheng Y, Zhang T, Yang C, Gebeyew K, Ye C, Zhou X Commun Biol. 2024; 7(1):1686.

PMID: 39706905 PMC: 11662026. DOI: 10.1038/s42003-024-07406-9.


β-Cell Regeneration Is Driven by Pancreatic Plasticity.

Holguin-Horcajo A, Sancho R, Rovira M Adv Anat Embryol Cell Biol. 2024; 239:91-115.

PMID: 39283483 DOI: 10.1007/978-3-031-62232-8_4.


Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes.

Cui D, Feng X, Lei S, Zhang H, Hu W, Yang S Chin Med J (Engl). 2024; 137(7):791-805.

PMID: 38479993 PMC: 10997226. DOI: 10.1097/CM9.0000000000003034.


GABA treatment does not induce neogenesis of new endocrine cells from pancreatic ductal cells.

Wang S, Dong X, Maazi M, Chen N, Mahil A, Kopp J Islets. 2023; 15(1):2219477.

PMID: 37258189 PMC: 10234131. DOI: 10.1080/19382014.2023.2219477.